These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|||||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
|
|
|
|
|||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code:
|
|
|
Not Applicable | ||
(Former name, former address and former fiscal year, if changed since last report) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
x | Accelerated filer |
¨
|
||||||||
Non-accelerated filer |
¨
|
Smaller reporting company |
|
||||||||
Emerging growth company |
|
Class A Common Stock |
Shares outstanding as of June 5, 2024
|
|||||||
$0.01 Par Value |
|
Item 1. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 5. | ||||||||
Item 6. | ||||||||
Abercrombie & Fitch Co. |
2
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
Net sales | $ |
|
$ |
|
|||||||||||||||||||||||||
Cost of sales, exclusive of depreciation and amortization |
|
|
|||||||||||||||||||||||||||
Gross profit |
|
|
|||||||||||||||||||||||||||
Stores and distribution expense |
|
|
|||||||||||||||||||||||||||
Marketing, general and administrative expense |
|
|
|||||||||||||||||||||||||||
Other operating income, net |
(
|
(
|
|||||||||||||||||||||||||||
Operating income |
|
|
|||||||||||||||||||||||||||
Interest expense |
|
|
|||||||||||||||||||||||||||
Interest income |
(
|
(
|
|||||||||||||||||||||||||||
Interest (income) expense, net |
(
|
|
|||||||||||||||||||||||||||
Income before income taxes |
|
|
|||||||||||||||||||||||||||
Income tax expense |
|
|
|||||||||||||||||||||||||||
Net income |
|
|
|||||||||||||||||||||||||||
Less: Net income attributable to noncontrolling interests |
|
|
|||||||||||||||||||||||||||
Net income attributable to A&F | $ |
|
$ |
|
|||||||||||||||||||||||||
Net income per share attributable to A&F | |||||||||||||||||||||||||||||
Basic | $ |
|
$ |
|
|||||||||||||||||||||||||
Diluted | $ |
|
$ |
|
|||||||||||||||||||||||||
Weighted-average shares outstanding | |||||||||||||||||||||||||||||
Basic |
|
|
|||||||||||||||||||||||||||
Diluted |
|
|
|||||||||||||||||||||||||||
Other comprehensive (loss) income | |||||||||||||||||||||||||||||
Foreign currency translation adjustments, net of tax | $ |
(
|
$ |
|
|||||||||||||||||||||||||
Derivative financial instruments, net of tax |
|
|
|||||||||||||||||||||||||||
Other comprehensive (loss) income |
(
|
|
|||||||||||||||||||||||||||
Comprehensive income |
|
|
|||||||||||||||||||||||||||
Less: Comprehensive income attributable to noncontrolling interests |
|
|
|||||||||||||||||||||||||||
Comprehensive income attributable to A&F | $ |
|
$ |
|
|||||||||||||||||||||||||
Abercrombie & Fitch Co. |
3
|
2024 1Q Form 10-Q
|
May 4, 2024 | February 3, 2024 | ||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and equivalents | $ |
|
$ |
|
|||||||
Receivables |
|
|
|||||||||
Inventories |
|
|
|||||||||
Other current assets |
|
|
|||||||||
Total current assets |
|
|
|||||||||
Property and equipment, net |
|
|
|||||||||
Operating lease right-of-use assets |
|
|
|||||||||
Other assets |
|
|
|||||||||
Total assets | $ |
|
$ |
|
|||||||
Liabilities and stockholders’ equity | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ |
|
$ |
|
|||||||
Accrued expenses |
|
|
|||||||||
Short-term portion of operating lease liabilities |
|
|
|||||||||
Income taxes payable |
|
|
|||||||||
Total current liabilities |
|
|
|||||||||
Long-term liabilities: | |||||||||||
Long-term portion of operating lease liabilities |
|
|
|||||||||
Long-term borrowings, net |
|
|
|||||||||
Other liabilities |
|
|
|||||||||
Total long-term liabilities |
|
|
|||||||||
Stockholders’ equity | |||||||||||
Class A Common Stock: $
|
|
|
|||||||||
Paid-in capital |
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Accumulated other comprehensive loss, net of tax (“AOCL”) |
(
|
(
|
|||||||||
Treasury stock, at average cost:
|
(
|
(
|
|||||||||
Total Abercrombie & Fitch Co. stockholders’ equity |
|
|
|||||||||
Noncontrolling interests |
|
|
|||||||||
Total stockholders’ equity |
|
|
|||||||||
Total liabilities and stockholders’ equity | $ |
|
$ |
|
Abercrombie & Fitch Co. |
4
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended May 4, 2024 | |||||||||||||||||||||||||||||
Common Stock |
Paid-in
capital |
Non-controlling interests |
Retained
earnings |
AOCL | Treasury stock |
Total
stockholders’ equity |
|||||||||||||||||||||||
Shares
outstanding |
Par
value |
Shares |
At average
cost |
||||||||||||||||||||||||||
Balance, February 3, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
Net income | — | — | — |
|
|
— | — | — |
|
||||||||||||||||||||
Purchase of Common Stock |
(
|
— | — | — | — | — |
|
(
|
(
|
||||||||||||||||||||
Share-based compensation issuances and exercises |
|
— |
(
|
— |
(
|
— |
(
|
(
|
(
|
||||||||||||||||||||
Share-based compensation expense | — | — |
|
— | — | — | — | — |
|
||||||||||||||||||||
Derivative financial instruments, net of tax | — | — | — | — | — |
|
— | — |
|
||||||||||||||||||||
Foreign currency translation adjustments, net of tax | — | — | — | — | — |
(
|
— | — |
(
|
||||||||||||||||||||
Distributions to noncontrolling interests, net | — | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||
Ending balance at May 4, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
Thirteen Weeks Ended April 29, 2023 | |||||||||||||||||||||||||||||
Common Stock |
Paid-in
capital |
Non-controlling interests |
Retained
earnings |
AOCL | Treasury stock |
Total
stockholders’ equity |
|||||||||||||||||||||||
Shares
outstanding |
Par
value |
Shares |
At average
cost |
||||||||||||||||||||||||||
Balance, January 28, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||
Net income | — | — | — |
|
|
— | — | — |
|
||||||||||||||||||||
Share-based compensation issuances and exercises |
|
— |
(
|
— |
(
|
— |
(
|
|
(
|
||||||||||||||||||||
Share-based compensation expense | — | — |
|
— | — | — | — | — |
|
||||||||||||||||||||
Derivative financial instruments, net of tax | — | — | — | — | — |
|
— | — |
|
||||||||||||||||||||
Foreign currency translation adjustments, net of tax | — | — | — | — | — |
|
— | — |
|
||||||||||||||||||||
Distributions to noncontrolling interests, net | — | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||
Ending balance at April 29, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
Abercrombie & Fitch Co. |
5
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||
Operating activities | |||||||||||
Net income | $ |
|
$ |
|
|||||||
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
|
|||||||||||
Depreciation and amortization |
|
|
|||||||||
Asset impairment |
|
|
|||||||||
Loss on disposal |
|
|
|||||||||
Provision for deferred income taxes |
|
|
|||||||||
Share-based compensation |
|
|
|||||||||
Loss on extinguishment of debt |
|
|
|||||||||
Changes in assets and liabilities: | |||||||||||
Inventories |
|
|
|||||||||
Accounts payable and accrued expenses |
(
|
(
|
|||||||||
Operating lease right-of-use assets and liabilities |
(
|
(
|
|||||||||
Income taxes |
|
|
|||||||||
Other assets |
(
|
(
|
|||||||||
Other liabilities |
|
|
|||||||||
Net cash provided by (used for) operating activities |
|
(
|
|||||||||
Investing activities | |||||||||||
Purchases of property and equipment |
(
|
(
|
|||||||||
Net cash used for investing activities |
(
|
(
|
|||||||||
Financing activities | |||||||||||
Purchase of senior secured notes |
(
|
|
|||||||||
Purchases of Common Stock |
(
|
|
|||||||||
Acquisition of Common stock for tax withholding obligations
|
(
|
(
|
|||||||||
Other financing activities |
(
|
(
|
|||||||||
Net cash used for financing activities |
(
|
(
|
|||||||||
Effect of foreign currency exchange rates on cash |
(
|
(
|
|||||||||
Net decrease in cash and equivalents, and restricted cash and equivalents |
(
|
(
|
|||||||||
Cash and equivalents, and restricted cash and equivalents, beginning of period |
|
|
|||||||||
Cash and equivalents, and restricted cash and equivalents, end of period | $ |
|
$ |
|
|||||||
Supplemental information related to non-cash activities | |||||||||||
Purchases of property and equipment not yet paid at end of period | $ |
|
$ |
|
|||||||
Operating lease right-of-use assets additions, net of terminations, impairments and other reductions |
|
|
|||||||||
Supplemental information related to cash activities | |||||||||||
Cash paid for interest |
|
|
|||||||||
Cash paid for income taxes |
|
|
|||||||||
Cash received from income tax refunds |
|
|
|||||||||
Cash paid for amounts included in measurement of operating lease liabilities, net of abatements |
|
|
Abercrombie & Fitch Co. |
6
|
2024 1Q Form 10-Q
|
Page No. | ||||||||
Note 1.
|
||||||||
Note 2.
|
||||||||
Note 3.
|
||||||||
Note 4.
|
||||||||
Note 5.
|
||||||||
Note 6.
|
||||||||
Note 7.
|
||||||||
Note 8.
|
||||||||
Note 9.
|
||||||||
Note 10.
|
||||||||
Note 11.
|
||||||||
Note 12.
|
||||||||
Note 13.
|
||||||||
Note 14.
|
||||||||
Abercrombie & Fitch Co. |
7
|
2024 1Q Form 10-Q
|
Fiscal year | Year ended/ending | Number of weeks | ||||||||||||
Fiscal 2023 | February 3, 2024 | 53 | ||||||||||||
Fiscal 2024 | February 1, 2025 | 52 | ||||||||||||
Fiscal 2025 | January 31, 2026 | 52 |
Abercrombie & Fitch Co. |
8
|
2024 1Q Form 10-Q
|
Accounting Standards Update (ASU) | Description | Effect on the financial statements or other significant matters | ||||||||||||||||||
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
|
The update modifies the disclosure/presentation requirements of reportable segments. The amendments in the update require the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (CODM) and included within each reported measure of segment profit and loss, The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources.This update is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted.
|
The Company is currently evaluating the impact that this guidance will have on its consolidated financial statements and accompanying notes | ||||||||||||||||||
ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures
|
The standard requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. For public business entities (PBEs), the requirement will be effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted.
|
Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company's consolidated financial statements.
|
(in thousands) | Location | May 4, 2024 | February 3, 2024 | April 29, 2023 | January 28, 2023 | ||||||||||||||||||||||||
Cash and equivalents | Cash and equivalents | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
Long-term restricted cash and equivalents | Other assets |
|
|
|
|
||||||||||||||||||||||||
Cash and equivalents and restricted cash and equivalents | $ |
|
$ |
|
$ |
|
$ |
|
Abercrombie & Fitch Co. |
9
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | ||||||||||||||||||||||
Confirmed obligations outstanding at the beginning of the period | $ |
|
|||||||||||||||||||||
Invoices confirmed during the period |
|
||||||||||||||||||||||
Confirmed invoices paid during the period |
(
|
||||||||||||||||||||||
Confirmed obligations outstanding at the end of the period | $ |
|
(in thousands) | May 4, 2024 | February 3, 2024 | April 29, 2023 | January 28, 2023 | |||||||||||||||||||
Gift card liability
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Loyalty programs liability |
|
|
|
|
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||
Revenue associated with gift card redemptions and gift card breakage | $ |
|
$ |
|
|||||||||||||||||||
Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs |
|
|
Abercrombie & Fitch Co. |
10
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||
Shares of Common Stock issued |
|
|
|||||||||||||||||||||
Weighted-average treasury shares |
(
|
(
|
|||||||||||||||||||||
Weighted-average — basic shares |
|
|
|||||||||||||||||||||
Dilutive effect of share-based compensation awards |
|
|
|||||||||||||||||||||
Weighted-average — diluted shares |
|
|
|||||||||||||||||||||
Anti-dilutive shares
(1)
|
|
|
Assets and Liabilities at Fair Value as of May 4, 2024
|
|||||||||||||||||||||||
(in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Derivative instruments
(2)
|
|
|
|
|
|||||||||||||||||||
Rabbi Trust assets
(3)
|
|
|
|
|
|||||||||||||||||||
Restricted cash equivalents
(1)
|
|
|
|
|
|||||||||||||||||||
Total assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Liabilities: | |||||||||||||||||||||||
Derivative instruments
(2)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
Assets and Liabilities at Fair Value as of February 3, 2024
|
|||||||||||||||||||||||
(in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Derivative instruments
(2)
|
|
|
|
|
|||||||||||||||||||
Rabbi Trust assets
(3)
|
|
|
|
|
|||||||||||||||||||
Restricted cash equivalents
(1)
|
|
|
|
|
|||||||||||||||||||
Total assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Liabilities: | |||||||||||||||||||||||
Derivative instruments
(2)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
Abercrombie & Fitch Co. |
11
|
2024 1Q Form 10-Q
|
(in thousands) | May 4, 2024 | February 3, 2024 | |||||||||
Gross borrowings outstanding, carrying amount | $ |
|
$ |
|
|||||||
Gross borrowings outstanding, fair value
(1)
|
|
|
(in thousands) | May 4, 2024 | February 3, 2024 | |||||||||
Property and equipment, at cost | $ |
|
$ |
|
|||||||
Less: Accumulated depreciation and amortization |
(
|
(
|
|||||||||
Property and equipment, net | $ |
|
$ |
|
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||
Single lease cost
(1)
|
$ |
|
$ |
|
|||||||||||||||||||
Variable lease cost
(2)
|
|
|
|||||||||||||||||||||
Operating lease right-of-use asset impairment
(3)
|
|
|
|||||||||||||||||||||
Sublease income
|
(
|
(
|
|||||||||||||||||||||
Total operating lease cost | $ |
|
$ |
|
Abercrombie & Fitch Co. |
12
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||
Operating lease right-of-use asset impairment | $ |
|
$ |
|
|||||||||||||||||||
Property and equipment asset impairment |
|
|
|||||||||||||||||||||
Total asset impairment | $ |
|
$ |
|
Abercrombie & Fitch Co. |
13
|
2024 1Q Form 10-Q
|
(in thousands) | May 4, 2024 | February 3, 2024 | |||||||||
Long-term portion of borrowings, gross at carrying amount | $ |
|
$ |
|
|||||||
Unamortized fees |
(
|
(
|
|||||||||
Long-term borrowings, net | $ |
|
$ |
|
Abercrombie & Fitch Co. |
14
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||
Share-based compensation expense | $ |
|
$ |
|
|||||||||||||||||||
Income tax benefits associated with share-based compensation expense recognized
|
|
|
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||||||||
Income tax discrete benefits realized for tax deductions related to the issuance of shares
|
$ |
|
$ |
|
|||||||||||||||||||||||||
Income tax discrete charges realized upon cancellation of stock appreciation rights |
|
(
|
|||||||||||||||||||||||||||
Total income tax discrete benefits related to share-based compensation awards
|
$ |
|
$ |
|
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||
Employee tax withheld upon issuance of shares
(1)
|
$ |
|
$ |
|
Service-based Restricted
Stock Units |
Performance-based Restricted
Stock Units |
Market-based Restricted
Stock Units |
|||||||||||||||||||||||||||||||||
Number of
Underlying Shares |
Weighted-
Average Grant Date Fair Value |
Number of
Underlying Shares |
Weighted-
Average Grant Date Fair Value |
Number of
Underlying Shares |
Weighted-
Average Grant Date Fair Value |
||||||||||||||||||||||||||||||
Unvested at February 3, 2024 |
|
$ |
|
|
$ |
|
|
$ |
|
||||||||||||||||||||||||||
Granted |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Adjustments for performance achievement
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Vested |
(
|
|
(
|
|
(
|
|
|||||||||||||||||||||||||||||
Forfeited |
(
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Unvested at May 4, 2024
(1)
|
|
$ |
|
|
$ |
|
|
$ |
|
Service-based Restricted
Stock Units |
Performance-based Restricted
Stock Units |
Market-based Restricted
Stock Units |
|||||||||||||||
Unrecognized compensation cost
(in thousands)
|
$ |
|
$ |
|
$ |
|
|||||||||||
Remaining weighted-average period cost is expected to be recognized (years) |
|
|
|
Abercrombie & Fitch Co. |
15
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||
Service-based restricted stock units: | |||||||||||
Total grant date fair value of awards granted | $ |
|
$ |
|
|||||||
Total grant date fair value of awards vested |
|
|
|||||||||
Performance-based restricted stock units: | |||||||||||
Total grant date fair value of awards granted |
|
|
|||||||||
Total grant date fair value of awards vested |
|
|
|||||||||
Market-based restricted stock units: | |||||||||||
Total grant date fair value of awards granted |
|
|
|||||||||
Total grant date fair value of awards vested |
|
|
Thirteen Weeks Ended | |||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||
Grant date market price | $ |
|
$ |
|
|||||||
Fair value |
|
|
|||||||||
Price volatility |
|
% |
|
% | |||||||
Expected term (years) |
|
|
|||||||||
Risk-free interest rate |
|
% |
|
% | |||||||
Dividend yield |
|
|
|||||||||
Average volatility of peer companies |
|
|
|||||||||
Average correlation coefficient of peer companies |
|
|
Number of
Underlying Shares |
Weighted-Average
Exercise Price |
Aggregate
Intrinsic Value
(in thousands)
|
Weighted-Average
Remaining Contractual Life (years) |
||||||||||||||||||||
Outstanding at February 3, 2024 |
|
$ |
|
||||||||||||||||||||
Exercised |
(
|
|
|||||||||||||||||||||
Forfeited or expired |
|
|
|||||||||||||||||||||
Outstanding at May 4, 2024
|
|
$ |
|
$ |
|
|
|||||||||||||||||
Stock appreciation rights exercisable at May 4, 2024 |
|
$ |
|
$ |
|
|
|||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||
Total grant date fair value of awards exercised | $ |
|
$ |
|
Abercrombie & Fitch Co. |
16
|
2024 1Q Form 10-Q
|
(in thousands) |
Notional Amount
(1)
|
||||
Euro | $ |
|
|||
British pound |
|
||||
Canadian dollar |
|
||||
(in thousands) |
Notional Amount
(1)
|
||||
British pound | $ |
|
|||
Euro |
|
||||
(in thousands) | Location | May 4, 2024 | February 3, 2024 | Location | May 4, 2024 | February 3, 2024 | |||||||||||||||||||||||||||||
Derivatives designated as cash flow hedging instruments |
Other current assets
|
$ |
|
$ |
|
Accrued expenses
|
$ |
|
$ |
|
|||||||||||||||||||||||||
Derivatives not designated as hedging instruments
|
Other current assets
|
|
|
Accrued expenses
|
|
|
|||||||||||||||||||||||||||||
Total
|
$ |
|
$ |
|
$ |
|
$ |
|
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||||||||
Gain (loss) recognized in AOCL
(1)
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||
Gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization
(2)
|
|
(
|
Abercrombie & Fitch Co. |
17
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | ||||||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||
Gain (loss) recognized in other operating income, net
|
$ |
|
$ |
(
|
Thirteen Weeks Ended May 4, 2024 | |||||||||||||||||
(in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
Beginning balance at February 3, 2024 | $ |
(
|
$ |
|
$ |
(
|
|||||||||||
Other comprehensive (loss) income before reclassifications |
(
|
|
(
|
||||||||||||||
Reclassified gain from AOCL
(1)
|
|
(
|
(
|
||||||||||||||
Tax effect |
|
(
|
(
|
||||||||||||||
Other comprehensive (loss) income after reclassifications |
(
|
|
(
|
||||||||||||||
Ending balance at May 4, 2024 | $ |
(
|
$ |
|
$ |
(
|
|||||||||||
Thirteen Weeks Ended April 29, 2023 | |||||||||||||||||
(in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
Beginning balance at January 28, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||
Other comprehensive income (loss) before reclassifications |
|
(
|
(
|
||||||||||||||
Reclassified loss from AOCL
(1)
|
|
|
|
||||||||||||||
Tax effect |
|
|
|
||||||||||||||
Other comprehensive income after reclassifications |
|
|
|
||||||||||||||
Ending balance at April 29, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||
Abercrombie & Fitch Co. |
18
|
2024 1Q Form 10-Q
|
Net Sales | |||||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||
Americas | $ |
|
$ |
|
|||||||||||||||||||
EMEA |
|
|
|||||||||||||||||||||
APAC |
|
|
|||||||||||||||||||||
Segment total | $ |
|
$ |
|
|||||||||||||||||||
Operating Income (Loss)
|
|||||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||
Americas | $ |
|
$ |
|
|||||||||||||||||||
EMEA |
|
(
|
|||||||||||||||||||||
APAC |
(
|
(
|
|||||||||||||||||||||
Segment total | $ |
|
$ |
|
|||||||||||||||||||
Operating (loss) income not attributed to segments:
|
|||||||||||||||||||||||
Stores and distribution expense |
(
|
(
|
|||||||||||||||||||||
Marketing, general and administrative expense |
(
|
(
|
|||||||||||||||||||||
Other operating income,net |
|
|
|||||||||||||||||||||
Total operating income | $ |
|
$ |
|
|||||||||||||||||||
Assets | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | February 3, 2024 | |||||||||||||||||||||
Inventories | |||||||||||||||||||||||
Americas | $ |
|
$ |
|
|||||||||||||||||||
EMEA |
|
|
|||||||||||||||||||||
APAC |
|
|
|||||||||||||||||||||
Total inventories | $ |
|
$ |
|
|||||||||||||||||||
Assets not attributed to segments
|
|
|
|||||||||||||||||||||
Total assets | $ |
|
$ |
|
Thirteen Weeks Ended | |||||||||||||||||||||||
(in thousands) | May 4, 2024 | April 29, 2023 | |||||||||||||||||||||
Abercrombie
(1)
|
$ |
|
$ |
|
|||||||||||||||||||
Hollister
(2)
|
|
|
|||||||||||||||||||||
Total | $ |
|
$ |
|
Abercrombie & Fitch Co. |
19
|
2024 1Q Form 10-Q
|
Abercrombie & Fitch Co. |
20
|
2024 1Q Form 10-Q
|
Abercrombie & Fitch Co. |
21
|
2024 1Q Form 10-Q
|
Fiscal year | Year ended/ending | Number of weeks | ||||||||||||
Fiscal 2023 | February 3, 2024 | 53 | ||||||||||||
Fiscal 2024 | February 1, 2025 | 52 | ||||||||||||
Fiscal 2025 | January 31, 2026 | 52 |
Abercrombie & Fitch Co. |
22
|
2024 1Q Form 10-Q
|
Abercrombie & Fitch Co. |
23
|
2024 1Q Form 10-Q
|
GAAP |
Non-GAAP
(1)
|
|||||||||||||||||||||||||
Thirteen Weeks Ended |
May 4, 2024
|
April 29, 2023
|
May 4, 2024
|
April 29, 2023
|
||||||||||||||||||||||
Net sales
(in thousands)
|
$ | 1,020,730 | $ | 835,994 | ||||||||||||||||||||||
Change in net sales | 22.1 | % | 2.9 | % | ||||||||||||||||||||||
Comparable sales
(2)
|
21 | % | 3 | % | ||||||||||||||||||||||
Gross profit rate | 66.4 | % | 61.0 | % | ||||||||||||||||||||||
Operating income
(in thousands)
|
$ | 129,849 | $ | 34,008 | $ | 129,849 | $ | 38,444 | ||||||||||||||||||
Operating income margin
|
12.7 | % | 4.1 | % | 12.7 | % | 4.6 | % | ||||||||||||||||||
Net income attributable to A&F
(in thousands)
|
$ | 113,850 | $ | 16,571 | $ | 113,850 | $ | 19,820 | ||||||||||||||||||
Net income per share attributable to A&F | 2.14 | 0.32 | 2.14 | 0.39 | ||||||||||||||||||||||
(in thousands) | May 4, 2024 | February 3, 2024 | ||||||||||||
Cash and equivalents | $ | 864,195 | $ | 900,884 | ||||||||||
Inventories | 449,267 | 469,466 | ||||||||||||
Gross long-term borrowings outstanding, carrying amount | 213,906 | 223,214 |
(in thousands) | May 4, 2024 | April 29, 2023 | ||||||||||||
Net cash provided by (used for) operating activities | $ | 95,010 | $ | (560) | ||||||||||
Net cash used for investing activities | (38,886) | (46,391) | ||||||||||||
Net cash used for financing activities | (92,951) | (21,956) |
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
(in thousands, except ratios) | May 4, 2024 | April 29, 2023 | $ Change | % Change |
Comparable
Sales
(1
)
|
||||||||||||||||||||||||
By segment: | |||||||||||||||||||||||||||||
Americas | $ | 820,121 | $ | 665,423 | $ | 154,698 | 23 | % | 21 | % | |||||||||||||||||||
EMEA | 164,778 | 138,106 | 26,672 | 19 | 23 | ||||||||||||||||||||||||
APAC | 35,831 | 32,465 | 3,366 | 10 | 22 | ||||||||||||||||||||||||
Total | $ | 1,020,730 | $ | 835,994 | $ | 184,736 | 22 | 21 | |||||||||||||||||||||
Abercrombie & Fitch Co. |
24
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
(in thousands, except ratios) | May 4, 2024 | April 29, 2023 | $ Change | % Change |
Comparable
Sales
(1)
|
||||||||||||||||||||||||
Abercrombie
(2)
|
$ | 571,513 | $ | 436,044 | $ | 135,469 | 31 | % | 29 | % | |||||||||||||||||||
Hollister
(3)
|
449,217 | 399,950 | 49,267 | 12 | 13 | ||||||||||||||||||||||||
Total | $ | 1,020,730 | $ | 835,994 | $ | 184,736 | 22 | 21 | |||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Cost of sales, exclusive of depreciation and amortization | $ | 343,273 | 33.6 | % | $ | 326,200 | 39.0 | % | (540) | ||||||||||||||||||||
Abercrombie & Fitch Co. |
25
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Gross profit, exclusive of depreciation and amortization | $ | 677,457 | 66.4 | % | $ | 509,794 | 61.0 | % | 540 | ||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Stores and distribution expense | $ | 371,686 | 36.4 | % | $ | 336,049 | 40.2 | % | (380) | ||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Marketing, general and administrative expense | $ | 177,880 | 17.4 | % | $ | 142,631 | 17.1 | % | 30 | ||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Other operating income, net | $ | 1,958 | 0.2 | % | $ | 2,894 | 0.3 | % | (10) | ||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Operating income | $ | 129,849 | 12.7 | % | $ | 34,008 | 4.1 | % | 860 | ||||||||||||||||||||
Excluded items: | |||||||||||||||||||||||||||||
Asset impairment charges
(1)
|
— | — | 4,436 | 0.5 | (50) | ||||||||||||||||||||||||
Adjusted non-GAAP operating income ⁽¹⁾ | $ | 129,849 | 12.7 | $ | 38,444 | 4.6 | 810 | ||||||||||||||||||||||
Abercrombie & Fitch Co. |
26
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Interest expense | $ | 5,780 | 0.6 | % | $ | 7,458 | 0.9 | % | (30) | ||||||||||||||||||||
Interest income | (10,803) | (1.1) | (4,015) | (0.5) | (60) | ||||||||||||||||||||||||
Interest (income) expense, net | $ | (5,023) | (0.5) | $ | 3,443 | 0.4 | (90) | ||||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||
(in thousands, except ratios) | Effective Tax Rate | Effective Tax Rate | |||||||||||||||||||||
Income tax expense | $ | 19,794 | 14.7 | % | $ | 12,718 | 41.6 | % | |||||||||||||||
Excluded items: | |||||||||||||||||||||||
Tax effect of pre-tax excluded items
(1)
|
— | 1,187 | |||||||||||||||||||||
Adjusted non-GAAP income tax expense ⁽¹⁾ | $ | 19,794 | 14.7 | $ | 13,905 | 39.7 | |||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
(in thousands) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Net income attributable to A&F | $ | 113,850 | 11.2 | % | $ | 16,571 | 2.0 | % | 920 | ||||||||||||||||||||
Excluded items, net of tax
(1)
|
— | — | 3,249 | 0.4 | (40) | ||||||||||||||||||||||||
Adjusted non-GAAP net income attributable to A&F
(2)
|
$ | 113,850 | 11.2 | $ | 19,820 | 2.4 | 880 | ||||||||||||||||||||||
Abercrombie & Fitch Co. |
27
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | |||||||||||||||||
May 4, 2024 | April 29, 2023 | $ Change | |||||||||||||||
Net income per diluted share attributable to A&F
|
$ | 2.14 | $ | 0.32 | $ | 1.82 | |||||||||||
Excluded items, net of tax
(1)
|
— | 0.06 | (0.06) | ||||||||||||||
Adjusted non-GAAP net income per diluted share attributable to A&F
|
2.14 | 0.39 | 1.75 | ||||||||||||||
Impact from changes in foreign currency exchange rates | — | — | — | ||||||||||||||
Adjusted non-GAAP net income per diluted share attributable to A&F on a constant currency basis
(2)
|
2.14 | 0.39 | 1.75 | ||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Net income | $ | 115,078 | 11.3 | % | $ | 17,847 | 2.1 | % | 920 | ||||||||||||||||||||
Income tax expense | 19,794 | 1.9 | 12,718 | 1.5 | 40 | ||||||||||||||||||||||||
Interest (income) expense, net | (5,023) | (0.5) | 3,443 | 0.4 | (90) | ||||||||||||||||||||||||
Depreciation and amortization | 37,689 | 3.7 | 36,028 | 4.4 | (70) | ||||||||||||||||||||||||
EBITDA
(1)
|
$ | 167,538 | 16.4 | % | $ | 70,036 | 8.4 | % | 800 | ||||||||||||||||||||
Excluded items: | |||||||||||||||||||||||||||||
Asset impairment charges
(1)
|
— | — | 4,436 | 0.5 | (50) | ||||||||||||||||||||||||
Adjusted EBITDA
(1)
|
$ | 167,538 | 16.4 | % | $ | 74,472 | 8.9 | % | 750 | ||||||||||||||||||||
Abercrombie & Fitch Co. |
28
|
2024 1Q Form 10-Q
|
Abercrombie & Fitch Co. |
29
|
2024 1Q Form 10-Q
|
(in thousands) | May 4, 2024 | ||||
Loan cap | $ | 325,648 | |||
Less: Outstanding stand-by letters of credit | (430) | ||||
Borrowing capacity | 325,218 | ||||
Less: Minimum excess availability
(1)
|
(32,565) | ||||
Borrowing capacity available | $ | 292,653 |
Thirteen Weeks Ended | |||||||||||
May 4, 2024 | April 29, 2023 | ||||||||||
(in thousands) | |||||||||||
Cash and equivalents, and restricted cash and equivalents, beginning of period | $ | 909,685 | $ | 527,569 | |||||||
Net cash provided by (used for) operating activities | 95,010 | (560) | |||||||||
Net cash used for investing activities | (38,886) | (46,391) | |||||||||
Net cash used for financing activities | (92,951) | (21,956) | |||||||||
Effect of foreign currency exchange rates on cash | (857) | (1,998) | |||||||||
Net decrease in cash and equivalents, and restricted cash and equivalents | (37,684) | (70,905) | |||||||||
Cash and equivalents, and restricted cash and equivalents, end of period | $ | 872,001 | $ | 456,664 |
Abercrombie & Fitch Co. |
30
|
2024 1Q Form 10-Q
|
Abercrombie & Fitch Co. |
31
|
2024 1Q Form 10-Q
|
Financial measures
(1)
|
Excluded items | |||||||
Operating income | Asset impairment charges | |||||||
Income tax expense
(2)
|
Tax effect of pre-tax excluded items | |||||||
Net income and net income per share attributable to A&F
(2)
|
Pre-tax excluded items and the tax effect of pre-tax excluded items |
(in thousands, except change in net sales, gross profit rate, operating margin and per share data) | Thirteen Weeks Ended | ||||||||||||||||||||||||||||||||||
Net sales | May 4, 2024 | April 29, 2023 | % Change | ||||||||||||||||||||||||||||||||
GAAP | $ | 1,020,730 | $ | 835,994 | 22 | % | |||||||||||||||||||||||||||||
Impact from changes in foreign currency exchange rates | — | (551) | — | ||||||||||||||||||||||||||||||||
Non-GAAP on a constant currency basis | $ | 1,020,730 | $ | 835,443 | 22 | ||||||||||||||||||||||||||||||
Gross profit, exclusive of depreciation and amortization expense | May 4, 2024 | April 29, 2023 |
BPS Change
(1)
|
||||||||||||||||||||||||||||||||
GAAP | $ | 677,457 | $ | 509,794 | 540 | ||||||||||||||||||||||||||||||
Impact from changes in foreign currency exchange rates | — | 930 | (10) | ||||||||||||||||||||||||||||||||
Non-GAAP on a constant currency basis | $ | 677,457 | $ | 510,724 | 530 | ||||||||||||||||||||||||||||||
Operating income | May 4, 2024 | April 29, 2023 |
BPS Change
(1)
|
||||||||||||||||||||||||||||||||
GAAP | $ | 129,849 | $ | 34,008 | 860 | ||||||||||||||||||||||||||||||
Excluded items
(2)
|
— | (4,436) | 50 | ||||||||||||||||||||||||||||||||
Adjusted non-GAAP | $ | 129,849 | $ | 38,444 | 810 | ||||||||||||||||||||||||||||||
Impact from changes in foreign currency exchange rates | — | 463 | (10) | ||||||||||||||||||||||||||||||||
Adjusted non-GAAP on a constant currency basis | $ | 129,849 | $ | 38,907 | 800 | ||||||||||||||||||||||||||||||
Net income per share attributable to A&F | May 4, 2024 | April 29, 2023 | $ Change | ||||||||||||||||||||||||||||||||
GAAP | $ | 2.14 | $ | 0.32 | $ | 1.82 | |||||||||||||||||||||||||||||
Excluded items, net of tax
(2)
|
— | (0.06) | 0.06 | ||||||||||||||||||||||||||||||||
Adjusted non-GAAP | $ | 2.14 | $ | 0.39 | $ | 1.75 | |||||||||||||||||||||||||||||
Impact from changes in foreign currency exchange rates | — | — | — | ||||||||||||||||||||||||||||||||
Adjusted non-GAAP on a constant currency basis | $ | 2.14 | $ | 0.39 | $ | 1.75 |
Abercrombie & Fitch Co. |
32
|
2024 1Q Form 10-Q
|
Thirteen Weeks Ended | ||||||||||||||||||||
May 4, 2024 |
% of
Net Sales |
April 29, 2023 |
% of
Net Sales |
|||||||||||||||||
Net income | $ | 115,078 | 11.3 | % | $ | 17,847 | 2.1 | % | ||||||||||||
Income tax expense | 19,794 | 1.9 | 12,718 | 1.5 | ||||||||||||||||
Interest (income) expense, net | (5,023) | (0.5) | 3,443 | 0.4 | ||||||||||||||||
Depreciation and amortization | 37,689 | 3.7 | 36,028 | 4.4 | ||||||||||||||||
EBITDA
(1)
|
$ | 167,538 | 16.4 | % | $ | 70,036 | 8.4 | % | ||||||||||||
Adjustments to EBITDA | ||||||||||||||||||||
Asset impairment
(1)
|
— | — | 4,436 | 0.5 | ||||||||||||||||
Adjusted EBITDA
(1)
|
$ | 167,538 | 16.4 | % | $ | 74,472 | 8.9 | % | ||||||||||||
Abercrombie & Fitch Co. |
33
|
2024 1Q Form 10-Q
|
Abercrombie & Fitch Co. |
34
|
2024 1Q Form 10-Q
|
Abercrombie & Fitch Co. |
35
|
2024 1Q Form 10-Q
|
Period (fiscal month) |
Total Number of Shares Purchased
(1)
|
Average Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(2)
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
(2)(3)
|
|||||||||||||||||||
February 4, 2024 through March 2, 2024 | 1,339 | $ | 121.37 | — | $ | 232,184,768 | |||||||||||||||||
March 3, 2024 through April 6, 2024 | 582,642 | 127.36 | 79,731 | 221,844,410 | |||||||||||||||||||
April 7, 2024 through May 4, 2024 | 42,217 | 116.83 | 39,733 | 217,184,802 | |||||||||||||||||||
Total | 626,198 | 126.64 | 119,464 | 217,184,802 |
Abercrombie & Fitch Co. |
36
|
2024 1Q Form 10-Q
|
Exhibit | Document | |||||||
3.1 | ||||||||
3.2 | ||||||||
10.1
|
||||||||
10.2
|
Form of Performance Share Award Agreement used to evidence the grant of performance share awards to associates (employees) of A&F and its subsidiaries under the Abercrombie & Fitch Co. 2016 Long-Term Incentive Plan for Associates on or after March 12, 2024
,
incorporated herein by reference to Exhibit 10.
43
to A&F’s
Annual Report on Form 10-K for the fiscal year ended
February 3, 2
0
24
(File No. 001-12107)
|
|||||||
10.3
|
|
|||||||
31.1 | ||||||||
31.2 | ||||||||
32.1 | ||||||||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its Inline XBRL tags are embedded within the Inline XBRL document.* | |||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document.* | |||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.* | |||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.* | |||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.* | |||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.* | |||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).* |
Abercrombie & Fitch Co. |
37
|
2024 1Q Form 10-Q
|
Abercrombie & Fitch Co. | ||||||||
Date: June 7, 2024
|
By: |
/s/ Scott D. Lipesky
|
||||||
Scott D. Lipesky | ||||||||
Executive Vice President, Chief Financial Officer and Chief Operating Officer
(Principal Financial Officer, Principal Accounting Officer and Authorized Officer) |
Abercrombie & Fitch Co. |
38
|
2024 1Q Form 10-Q
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Paul J. Romanowski President and Chief Executive Officer Background and Experience Mr. Romanowski has significant leadership experience in the Company and has extensive knowledge of our business. • President and Chief Executive Officer, D.R. Horton, Inc. (October 2023 to present) • Executive Vice President and Co-Chief Operating Officer, D.R. Horton, Inc. (October 2021 to September 2023) • Region President, Florida and Gulf Coast, D.R. Horton, Inc. (2014 to 2021), and five Mid-Atlantic states (2019 to 2021) • Division President, South Florida, D.R. Horton, Inc. (1999 to 2014) • Land Acquisition Manager, M/I Homes (1997 to 1999) • South Florida Director, Metrostudy (1992 to 1997) Mr. Romanowski graduated from Butler University in 1992 with a bachelor of business administration degree in marketing. | |||
Michael R. Buchanan Retired Sr. Advisor, Banc of America Securities Background and Experience Mr. Buchanan has significant commercial banking experience with several banking institutions serving the real estate and homebuilding sectors. • Senior Advisor, Banc of America Securities (2002 to 2003) • Managing Director, Head of National Real Estate Banking Group, Bank of America (1998 until his retirement in 2002) • Executive Vice President of NationsBank, which later merged with Bank of America (1990 to 1998) • Director, Piedmont Office Realty Trust (NYSE: PDM) (2015 to 2021) | |||
Maribess L. Miller Retired Partner, PricewaterhouseCoopers Background and Experience Ms. Miller, a certified public accountant, has significant experience with both public and private companies gained from leading auditing and consulting engagements. • Practice Partner, PricewaterhouseCoopers (PwC) (1984 until retirement in 2009) • Managing Partner, North Texas Market (2002 to 2009) • Practice Leader, the Southwest Region Consumer, Industrial and Energy practice (1998 to 2002) • Managing Partner of PwC’s US Healthcare Audit Practice (1995 to 1998) • Director, Triumph Financial, Inc. (NASDAQ: TFIN) (2014 to present) • Director, Zix Corporation (2010 to 2021) | |||
Elaine D. Crowley Retired CFO, Mattress Giant Corporation Background and Experience Ms. Crowley, a certified public accountant, is an accomplished financial executive with deep expertise in accounting, finance, operational efficiency and public company leadership. • Executive Vice President and CFO, Mattress Giant Corporation (2010 to 2012) • CFO, Michaels Stores, Inc. (2008 to 2010) • CFO, The Bombay Company, Inc. (2000 to 2008) • Various roles including Controller, The Bombay Company, Inc. (1990 to 2000) • Various roles including Senior Manager, Price Waterhouse (now PwC) (1981 to 1990) • Director, Tandy Leather Factory, Inc. (NASDAQ: TLF) (2021 to 2024) • Director, Stage Stores, Inc. (2014 to 2020) | |||
David V. Auld Executive Chairman Background and Experience Mr. Auld has significant experience leading the Company and has unrivaled knowledge of all aspects of our business. • Executive Chairman, D.R. Horton, Inc. (May 2024 to present) • Executive Vice Chair, D.R. Horton, Inc. (October 2023 to May 2024) • President and Chief Executive Officer, D.R. Horton, Inc. (2014 to September 2023) • Executive Vice President and Chief Operating Officer, D.R. Horton, Inc. (2013 to 2014) • Region President, Florida, North and South Carolina, Georgia and Alabama, D.R. Horton, Inc. (2005 to 2013) • Division President, D.R. Horton, Inc. (1988 to 2005) • Texas American Bank (1982 to 1988) and General Dynamics (1979 to 1982) Mr. Auld graduated from Texas Tech University in 1978 with a bachelor of business administration degree in accounting. | |||
M. Chad Crow Retired President & CEO, Builders FirstSource Background and Experience Mr. Crow has significant public company executive leadership experience in the building products industry. • President and CEO, Builders FirstSource (NYSE: BLDR) (2017 until retirement in 2021) • COO, Builders FirstSource (2014 to 2017) • CFO, Builders FirstSource (2009 to 2014) • Various positions including Controller, Builders FirstSource (1999 to 2009) • Various roles, Pier 1 Imports (1995 to 1999) • Various roles, Price Waterhouse LLP (now PwC) (1991 to 1995) • Director, LOAR Holdings Inc. (NYSE: LOAR) (April 2024 to present) • Director, Builders FirstSource (NYSE: BLDR) (1999 to 2021) | |||
Brad S. Anderson Vice Chair of Cushman & Wakefield Background and Experience Mr. Anderson has significant experience in leadership roles in the homebuilding and real estate industries. • Vice Chair of Cushman & Wakefield, a global real estate services firm (2021 to present) • Executive Vice President of CBRE Group, Inc., an international real estate brokerage company (2009 to 2021) • Various leadership positions, CB Commercial Real Estate Group, Inc., (1987 to 2009) • Director, KS StateBank (2016 to present) • Interim Chair of the Board of Continental Homes Holding Corp. (1997 to 1998 when it merged with D.R. Horton) | |||
Benjamin S. Carson, Sr. Former Secretary of U.S. HUD Background and Experience Dr. Carson has significant leadership experience in governmental, regulatory and medical roles. • 17 th Secretary of U.S. HUD (2017 to 2021) • Led programs focused on advancing economic opportunity; providing safe, fair and affordable housing; spurring reinvestment in communities; reducing homelessness; assisting self-sufficiency to underserved and vulnerable populations; and helping disaster victims • Led the collaboration of eight federal agencies to establish the White House Council on Eliminating Regulatory Barriers to Affordable Housing • Distinguished career in the field of medicine including: • Director of the Division of Pediatric Neurosurgery at the Johns Hopkins Medical Institutions (1984 to 2013) • Professor of Neurological Surgery, Oncology, Plastic Surgery and Pediatrics at the Johns Hopkins Medical Institutions (1999 to 2013) • Director Experience: • Galectin Therapeutics Inc. (NASDAQ: GALT) (2023 to present) • Sinclair Broadcast Group, Inc. (NYSE: SBGI) (2022 to present) • Covenant Logistics Group, Inc. (NASDAQ: CVLG) (2021 to present) • Costco Wholesale Corporation (NASDAQ: COST) (1999 to 2015) • Kellogg Company (NYSE: K) (1997 to 2015) | |||
Barbara R. Smith Retired Chairman & CEO, Commercial Metals Company Background and Experience Ms. Smith has significant business leadership and management experience as a public company executive in the metals manufacturing industry. • Chairman of the Board, Commercial Metals Company (NYSE: CMC) (2018 until retirement in 2024) • CEO, Commercial Metals Company (2017 to 2023) • COO, Commercial Metals Company (2016 to 2017) • CFO, Commercial Metals Company (2011 to 2016) • CFO, Gerdau Ameristeel Corporation (2007 to 2011) • CFO, FARO Technologies, Inc. (2005 to 2006) • Various Roles, Alcoa Inc. (1981 to 2005) • Director, Comerica Incorporated (NYSE: CMA) (2017 to present) • Director, Minerals Technologies Inc. (NYSE: MTX) (2011 to 2017) |
Name and Current Principal Position |
Year |
Salary |
Bonus |
Stock Awards |
Non-Equity Incentive Plan Compensation |
Change in Pension Value and Non-Qualified Deferred Compensation Earnings |
All Other Compensation |
Total |
||||||||||||||||||||||||||||||||
David V. Auld Executive Chairman |
2024 | $ | 700,000 | — | $ | 13,773,848 | $ | 3,142,380 | $ | 177,167 | $ | 80,350 | $ | 17,873,745 | ||||||||||||||||||||||||||
2023 | $ | 700,000 | — | $ | 24,791,961 | $ | 6,314,709 | $ | 196,287 | $ | 79,900 | $ | 32,082,857 | |||||||||||||||||||||||||||
2022 | $ | 700,000 | — | $ | 21,987,160 | $ | 7,000,138 | $ | 230,414 | $ | 79,150 | $ | 29,996,862 | |||||||||||||||||||||||||||
Paul J. Romanowski President and Chief Executive Officer |
2024 | $ | 700,000 | — | $ | 19,565,399 | $ | 4,713,415 | $ | 86,905 | $ | 80,350 | $ | 25,146,069 | ||||||||||||||||||||||||||
2023 | $ | 500,000 | — | $ | 7,219,367 | $ | 6,314,679 | $ | 95,396 | $ | 59,900 | $ | 14,189,342 | |||||||||||||||||||||||||||
2022 | $ | 500,000 | — | $ | 5,447,599 | $ | 7,629,749 | $ | 110,780 | $ | 59,150 | $ | 13,747,278 | |||||||||||||||||||||||||||
Michael J. Murray Executive Vice President and Chief Operating Officer |
2024 | $ | 500,000 | — | $ | 15,968,950 | $ | 3,927,981 | $ | 73,338 | $ | 60,350 | $ | 20,530,619 | ||||||||||||||||||||||||||
2023 | $ | 500,000 | — | $ | 7,219,367 | $ | 6,314,679 | $ | 80,061 | $ | 59,900 | $ | 14,174,007 | |||||||||||||||||||||||||||
2022 | $ | 500,000 | — | $ | 5,447,599 | $ | 7,629,749 | $ | 92,368 | $ | 59,150 | $ | 13,728,866 | |||||||||||||||||||||||||||
Bill W. Wheat Executive Vice President and Chief Financial Officer |
2024 | $ | 500,000 | — | $ | 12,393,229 | $ | 3,142,380 | $ | 103,994 | $ | 60,350 | $ | 16,199,953 | ||||||||||||||||||||||||||
2023 | $ | 500,000 | $ | 3,000,000 | $ | 4,812,911 | — | $ | 114,707 | $ | 59,900 | $ | 8,487,518 | |||||||||||||||||||||||||||
2022 | $ | 500,000 | $ | 3,000,000 | $ | 3,363,589 | — | $ | 133,972 | $ | 59,150 | $ | 7,056,711 |
Customers
Customer name | Ticker |
---|---|
Target Corporation | TGT |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
Auld David V | - | 890,672 | 211,200 |
WHEAT BILL W | - | 295,777 | 0 |
WHEAT BILL W | - | 219,115 | 0 |
Romanowski Paul J | - | 141,800 | 0 |
Romanowski Paul J | - | 86,694 | 0 |
Murray Michael J | - | 35,973 | 31,630 |
ANDERSON BRADLEY S | - | 34,719 | 0 |
Murray Michael J | - | 33,769 | 29,057 |
Miller Maribess L | - | 18,488 | 0 |
Odom Aron M. | - | 8,529 | 0 |
Allen Barbara K | - | 5,650 | 0 |
Odom Aron M. | - | 4,103 | 0 |
BUCHANAN MICHAEL R | - | 1,487 | 8,136 |
HORTON DONALD R | - | 0 | 4,061,470 |
HORTON DONALD R | - | 0 | 4,307,230 |